Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort
- PMID: 26201037
- PMCID: PMC4511957
- DOI: 10.1097/MPH.0000000000000307
Guidelines for the Standard Monitoring of Patients With Thalassemia: Report of the Thalassemia Longitudinal Cohort
Abstract
Chronic transfusion therapy has played a central role in extending life expectancy for patients with hemoglobinopathies such as thalassemia. However, this life-saving therapy is associated with numerous complications that now comprise the bulk of management considerations for patients with thalassemia. This review reports on the experience of the Thalassemia Longitudinal Cohort and reviews available literature to establish guidelines for the management of patients with thalassemia.
Similar articles
-
New updating into hemoglobinopathies.Int J Lab Hematol. 2012 Dec;34(6):559-65. doi: 10.1111/j.1751-553X.2012.01446.x. Epub 2012 Jul 5. Int J Lab Hematol. 2012. PMID: 22762348 Review.
-
Interaction of alpha-thalassemia with other hemoglobinopathies in the eastern province of Saudi Arabia.Birth Defects Orig Artic Ser. 1987;23(5A):343-7. Birth Defects Orig Artic Ser. 1987. PMID: 3689916 No abstract available.
-
Transfusion therapy in congenital hemolytic anemias.Hematol Oncol Clin North Am. 1994 Dec;8(6):1053-86. Hematol Oncol Clin North Am. 1994. PMID: 7860437 Review.
-
Elevated exhaled carbon monoxide concentration in hemoglobinopathies and its relation to red blood cell transfusion therapy.Pediatr Hematol Oncol. 2010 Mar;27(2):112-21. doi: 10.3109/08880010903536227. Pediatr Hematol Oncol. 2010. PMID: 20201692
-
Clinical management of sickle cell hemoglobinopathies during pregnancy.Clin Perinatol. 1985 Oct;12(3):585-97. Clin Perinatol. 1985. PMID: 3902313 Review.
Cited by
-
Healthcare resource utilization and direct costs of transfusion-dependent thalassemia patients in Dubai, United Arab Emirates: a retrospective cost-of-illness study.BMC Health Serv Res. 2022 Mar 5;22(1):304. doi: 10.1186/s12913-022-07663-6. BMC Health Serv Res. 2022. PMID: 35248046 Free PMC article.
-
The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.Elife. 2021 May 18;10:e68217. doi: 10.7554/eLife.68217. Elife. 2021. PMID: 34002695 Free PMC article.
-
Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.Biol Blood Marrow Transplant. 2018 Jun;24(6):1216-1222. doi: 10.1016/j.bbmt.2018.01.023. Epub 2018 Jan 31. Biol Blood Marrow Transplant. 2018. PMID: 29374585 Free PMC article. Clinical Trial.
-
Thalassemia in the emergency department: special considerations for a rare disease.Ann Hematol. 2020 Sep;99(9):1967-1977. doi: 10.1007/s00277-020-04164-6. Epub 2020 Jul 3. Ann Hematol. 2020. PMID: 32621178 Free PMC article. Review.
-
A Comparison of Pain Before and After Transfusion in Adult transfusion-dependent thalassemia (TDT) Using BPI-SF.F1000Res. 2024 Aug 9;12:1425. doi: 10.12688/f1000research.75952.2. eCollection 2023. F1000Res. 2024. PMID: 39319245 Free PMC article.
References
-
- Weatherall DJ, Williams TN, Allen SJ, O'Donnell A. The population genetics and dynamics of the thalassemias. Hematol Oncol Clin N Am. 2010;24:1021–1031. - PubMed
-
- Borgna-Pignatti C, Rugolotto S, De Stefano P, et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxmine. Haematologia. 2004;89:1187–1193. - PubMed
-
- Sirchia G, Zanella A, Parravicini A, et al. Red cell alloantibodies in thalassemia major. Results of an Italian cooperative study. Transfusion. 1985;25:110–112. - PubMed
Publication types
MeSH terms
Grants and funding
- T32 HL007574/HL/NHLBI NIH HHS/United States
- U01 HL065244/HL/NHLBI NIH HHS/United States
- U01 HL065233/HL/NHLBI NIH HHS/United States
- U01 HL072291/HL/NHLBI NIH HHS/United States
- UL1 RR024996/RR/NCRR NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- U01 HL065238/HL/NHLBI NIH HHS/United States
- U01-HL65233/HL/NHLBI NIH HHS/United States
- U01-HL65244/HL/NHLBI NIH HHS/United States
- U01-HL65238/HL/NHLBI NIH HHS/United States
- U01-HL72291/HL/NHLBI NIH HHS/United States
- U01 HL065239/HL/NHLBI NIH HHS/United States
- UL1 TR002384/TR/NCATS NIH HHS/United States
- UL1-RR-025758/RR/NCRR NIH HHS/United States
- UL1-RR024134/RR/NCRR NIH HHS/United States
- UL1-RR024996/RR/NCRR NIH HHS/United States
- ULI-RR024131/RR/NCRR NIH HHS/United States
- U01-HL65239/HL/NHLBI NIH HHS/United States
- UL1 RR025758/RR/NCRR NIH HHS/United States
- U01-HL65232/HL/NHLBI NIH HHS/United States
- U01 HL065232/HL/NHLBI NIH HHS/United States
- UL1 RR024134/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical